● Honored with Animal Pharm Award - Best Company Asia and Australasia 2018
● Export Antican® to Macau
● Antican®- granted with Sponsor Fee Waiver FY 2019 by the US FDA
● Supplement for pets with cancer - Antican Synmax, officially launched in Taiwan
2018
Q1
● Pathological diagnosis case numbers successfully achieved quarterly target
● Established subsidiary in China, entered and stationing in Dongguan Songshan Lake Technology Park
● Launched “Love & Never Give Up!” the healthcare checkup program for pet cancer
● Co-endorsement of Antican® by Jih-Jong Lee, D.V.M., Director of Animal Cancer Treatment Center, National Taiwan University Veterinary Hospital and Shih-Chieh Chang, D.V.M., Director of Clinical Oncology, Former Dean of Veterinary Medical Teaching Hospital of National Chung Hsing University
Q2
● Distribution agreement execution with Northern Cyprus agent, marking a new expansion in the global market
● Successful formation of the total solution for pet cancer: Cancer Prevention – Antrodia Camphorata and Post-surgery Nutritional Supplement- Omega PLUS had been officially launched in Taiwan market
Q3
● Export Antican® to Northern Cyprus
● Distribution Agreement execution with Macau distributor
● Pet supplements launched on e-Commerce websites
Q4
● Antican® New Precision Medicine officially launched in Taiwan
● Vetco technical support team provided Antican® training seminar for distributor and veterinarians in Northern Cyprus
● Antican® Registration Pass COA New Drug Committe Review
Q2
● Recommended by the Council of Agriculture to Represent Taiwan to Participate in 2017 BIO International Convention in United States
Q3
● License of Antican® granted in Taiwan
Q4
● Official launch of Antican® in Taiwan
2016
Q1
● Successful Unblinding of Antican® Clinical Trial
Q2
● Recommended by the Council of Agriculture, Taiwan to Participate in 2016 BIO International Convention in United States and Interact with International Pharmaceutical Companies
● Official Operation of the Pathology Diagnostic Center
Q3
● Granted with Bronze Award for 2016 Taiwan Health and Agricultural Industry Competition
● Recommended by the Council of Agriculture, Taiwan to Participate in 2016 Asia Pet Show
Q4
● Obtained Successful Business Guarantee by the Credit Guarantee Fund of Taiwan
●Granted with 2016 Agribusiness Science and Technology Innovation Award by the Council of Agriculture
●Invited by nternational Pharmaceutical Company to Participate in the Hong Kong Asia Animal Health Investment Forum, Interact with Major Asian Pharmaceutical Companies
2015
Q1
● Launching of the World's First Chinese Professional 「Small Animal Oncology」 Book
● Granted with Public Offering Company Qualification, Stock Code: 6520
● Official Initiation of Antican® Clinical Trial in Taiwan
Q3
● Product Development Meeting with US FDA
● Official Promotion of Taiwan Regional Cancer Treatment Center
● Antican® - Granted with Sponsor Fee Waiver FY 2016 by the US FDA
2014
Q1
● INAD Established with US FDA
Q2
● Participate in Nuremberg Pet Exposition in Germany and Contact with International Distributors
● Granted with Biotechnology Company Qualification by the Ministry of Economic Affairs
Q3
● Antican® - Granted with Sponsor Fee Waiver FY 2014 by the US FDA
● Executed MOU with European, Australian and Malaysian potential collaborators
● Granted with Leading Novel Product Program Subsidy by the Ministry of Economic Affairs, Taiwan
● Obtained Manufacturing License by the Council of Agriculture for Antican® Clinical Batch Production
● Antican® - Granted with Sponsor Fee Waiver FY 2015 by the US FDA
2013
Q4
● Council of Agriculture, Taiwan Granted Permission to Conduct Antican® Clinical Trial
